• Results
  • Access strategies: Results Part III: What does access look like for healthcare pra...
Access strategies: Results Part III

What does access look like for healthcare practitioner-administered products?

This part three of a four part series, describes how medicines that need to be administered by a healthcare professional can face a number of access challenges in low- and middle-income countries. This analysis looks at whether companies tailor their access strategies for these products to reach a larger proportion of patients in these countries.

Explore further

How we measure

How we measure

The Index evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to make change, such as R&D and pricing. Find out more about the analytical framework and areas of evaluation.

Get in touch

Back to top |